Skip to main content

Table 4 Results of the partial one-way sensitivity analyses

From: Cost-effectiveness analysis of combining traditional Chinese medicine in the treatment of hypertension: compound Apocynum tablets combined with Nifedipine sustained-release tablets vs Nifedipine sustained-release tablets alone

  Cost QALY CER ICER Results
Compound Apocynum+Nifedipine Nifedipine Compound Apocynum+Nifedipine Nifedipine Compound Apocynum+Nifedipine Nifedipine
Base-case 1739.87 1095.73 12.69 12.50 137.11 87.66 3390.23 Dominant
P020_n increase10% 1739.87 1095.73 12.69 12.50 137.11 87.66 3390.23 Dominant
P020_n decrease 10% 1739.87 1095.73 12.94 12.75 134.46 85.94 3390.23 Dominant
C_cn increase 10% 1739.87 1095.73 11.41 11.26 152.49 97.31 4294.29 Dominant
C_cn decrease 10% 1870.81 1095.73 12.69 12.50 147.42 87.66 4079.39 Dominant
P021_n increase 10% 1608.93 1095.73 12.69 12.50 126.79 87.66 2701.07 Dominant
P021_n decrease 10% 1767.03 1095.73 12.68 12.50 139.36 87.66 3729.44 Dominant
P021_cn increase 10% 1712.65 1095.73 12.69 12.50 134.96 87.66 3246.96 Dominant
P021_cn decrease 10% 1739.87 1095.73 12.70 12.51 137.00 87.59 3390.23 Dominant
u_Pstorke increase 10% 1739.87 1095.73 12.68 12.49 137.21 87.73 3390.23 Dominant
u_Pstroke decrease 10% 1751.94 1095.73 12.68 12.50 138.17 87.66 3645.64 Dominant
  1. (P020_n: Transition probability from alive without stroke/MI to stroke in Nifedipine; c_cn: Compound Apocynum+Nifedipine; P021_n: Transition probability from alive without stroke/MI to MI in Nifedipine; P021_cn: Transition probability from alive without stroke/MI to MI in the compound Apocynum+Nifedipine group; u_Pstroke: Utility of post-stroke.)